Arcadia Biosciences, Inc. — Director's Dealing 2018

Mar 17, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Arcadia Biosciences, Inc. (RKDA)
CIK: 0001469443
Period of Report: 2018-03-14

Reporting Person: Rey Eric J. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-03-14	Common Stock	M	21005	$21.60	Acquired	28340	Direct
2018-03-14	Common Stock	S	21005	$45.209	Disposed	7335	Direct
2018-03-15	Common Stock	M	250	$44.80	Acquired	7585	Direct
2018-03-15	Common Stock	S	250	$60.00	Disposed	7335	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-03-14	Employee Stock Option (right to buy)	$21.60	M	21005	Disposed	2018-06-30	Common Stock (21005)	Direct
2018-03-15	Employee Stock Option (right to buy)	$44.88	M	250	Disposed	2019-11-01	Common Stock (250)	Direct

Footnotes

F1: The security transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 Stock Trading Plan adopted by the Reporting Person effective June 6, 2017.

F2: This transaction was executed in multiple trades at prices ranging from $38.00 to $49.80. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3: The option is fully exercisable as of the date hereof.